Stage 0 Charcot Neuroarthropathy in the Diabetic Foot: An Emerging Narrow Window of Opportunity?


Journal

The international journal of lower extremity wounds
ISSN: 1552-6941
Titre abrégé: Int J Low Extrem Wounds
Pays: United States
ID NLM: 101128359

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 8 5 2021
medline: 10 11 2022
entrez: 7 5 2021
Statut: ppublish

Résumé

In a world where popular culture and concepts can become the norm without all the rigors of normal scrutiny, our attention is focused on identifying Charcot neuroarthropathy (CN) at a stage before radiological bone destruction occurs. The rationale is that early recognition can prevent a destructive chain of events and thus potentially reduce the burden to patients and health care providers. In this article, we describe the evolution of stage 0 CN, and the use of modern imaging in characterizing the abnormalities recognized by these modalities and how they aid our understanding and supplement our knowledge. We review the potential of these imaging modalities, assessing how far we have come in characterizing stage 0 and if we have robust criteria for the identification of stage 0 in the natural history of CN.

Identifiants

pubmed: 33960848
doi: 10.1177/15347346211011844
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

374-376

Auteurs

Raju Ahluwalia (R)

8948King's College Hospital, London, UK.

David G Armstrong (DG)

12223Keck School of Medicine of USC, Los Angeles, CA, USA.

Nina Petrova (N)

8948King's College Hospital, London, UK.
King's College, London, UK.

Nikoloas Papanas (N)

Democritus University of Thrace, Alexandroupolis, Greece.

Michael Edmonds (M)

8948King's College Hospital, London, UK.
King's College, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH